INDGN
Indegene Limited
Healthcare Research, Analytics & Technology
Share price
₹658
Market cap
₹15,850 Cr
1Y return
▲ 28%
A provider of analytics, technology, and specialized services to life science and healthcare organizations worldwide. Indegene delivers integrated solutions spanning commercial, medical, regulatory, and safety domains, combining data-driven insights with advanced technology platforms. The company serves pharmaceutical, biotech, and healthcare firms seeking to optimize operations, enhance decision-making, and improve market performance through evidence-based approaches and digital transformation.
Investors holding Indegene Limited
4.68%
1.94%
1.34%
Recent moves 21
Moves21
1move in the last 30 days
Members onlySBI Mutual FundExited
SBI Mutual Fund, which previously held a 1.27 percent stake in Indegene Limited, is no longer listed among the company's major shareholders, signaling either a complete exit or a reduction to below the 1 percent reporting threshold.
Read more
FidelityDecreased
Fidelity cut its stake in Indegene from 1.50% to 1.34%, selling 3,63,177 shares. The fund family now holds 32,39,460 shares of the company.
Read more
Sundaram Mutual FundIncreased
Sundaram Mutual Fund raised its stake in Indegene Limited from 1.90% to 1.94%, buying 85,270 shares.
Read more
American Funds (Capital Group)Decreased
American Funds (Capital Group) cut its stake in Indegene from 1.42% to 1.31%, selling 2,51,370 shares.
Read more
Quant Mutual FundNew position
Quant Mutual Fund added over 3.68% of Indegene in the quarter and now holds 4.68%, or 1,12,65,313 shares.
Read more
ICICI Prudential Mutual FundIncreased
ICICI Prudential Mutual Fund raised its stake in Indegene Limited from 1.19% to 3.11%, purchasing 46,30,521 shares.
Read more
Quant Mutual FundNew position
Quant Mutual Fund bought 9,523,810 shares of Indegene Limited for ₹500.00 Cr at ₹525.00 apiece in a block deal.
Read more
Government Pension Fund Global (Norway)Increased
Government Pension Fund Global (Norway) bought 4,80,000 shares of Indegene Limited for ₹25.20 Cr at ₹525.00 apiece in a block deal.
Read more
Morgan StanleyNew position
Morgan Stanley bought 665,048 shares of Indegene Limited in a block deal on August 6, 2026, for ₹34.92 crore at ₹525.00 apiece.
Read more
ICICI Prudential Mutual FundNew position
ICICI Prudential Mutual Fund bought 67,67,239 shares of Indegene Limited for ₹355.28 Cr at ₹525.00 apiece in a block deal.
Read more
Track the whales in Indegene Limited
Get alerted the moment a top investor buys or sells.
Start 7 days for ₹1